The Fort Worth Press

Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole

At US President Donald Trump's new migrant detention center in the Florida Everglades, time has no discernible meaning.

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology

Marketing approval allows imminent commercialization of the Colovac device in key EU markets

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third quarter can be viewed on the SEC Filings page of its Investor Relations website. The Company will not host a conference call to discuss these results. Applied DNA investor relations remains available for questions at [email protected] .

Laser Photonics (NASDAQ: LASE) Launches One-Year Integrated Media Partnership with New to The Street

Comprehensive campaign features long-form national TV interviews as sponsored programming, monthly earned media, high-frequency commercials, and iconic outdoor advertising

Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy

TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the termination of its equity purchase agreement ("ELOC") with Hudson Global Ventures, LLC.

Interactive Strength Inc. (Nasdaq:TRNR) Reports Second Quarter 2025 Results; Increases 2025 Pro Forma Revenue Guidance to More Than $80M

Company Reports Quarterly Revenue of $1.2 Million; Net Loss and Loss per Diluted Share of $2.2 Million and $2.13Quarterly Adjusted EBITDA Loss of $1.7 Million Reflects 40% YOY ImprovementTRNR held 29.6 Million FET tokens as of June 30, 2025 and 67.4 Million FET tokens as of August 13, 2025, with a value in excess of $50 million, representing the largest publicly traded AI-focused Digital Asset TreasuryStockholders' Equity Was $16.3 Million at Quarter End2025 Pro Forma Revenue Guidance Increased to more than $80 Million, driven by Sportstech's Stronger-Than-Expected Performance, and Fourth Quarter Profitability Guidance Reiterated

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue

The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of approximately $2.2 million and increased approximately 10% versus net Q2 2024 revenue of approximately $2.7 millionMytesi prescription volume increased approximately 6.5% in Q2 2025 over Q1 2025 and Mytesi prescription volume in Q2 2025 was equal to the volume in Q2 2024As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in USCompany strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for JaguarREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q2 2025 financials and company updates; Click here to register

ANITA & ZAHA Introduces Exclusive "Made in France" Natural Cosmetics

ANITA & ZAHA unveils a premium natural cosmetics range made in France, blending over 93% natural ingredients, luxury design, and eco-conscious values for modern, mindful beauty lovers.

Storm makes landfall in China after raking Taiwan as typhoon

Typhoon Podul weakened to a severe tropical storm when it roared ashore in southeastern China early Thursday, state media said, after carving a path across Taiwan, shutting down businesses, grounding flights and knocking out power to thousands of homes.

At least 26 migrants dead in two shipwrecks off Italy

At least 26 migrants died Wednesday when two boats sank off the coast of Italy's Lampedusa island, with around 10 others still missing, the coastguard and UN officials said.

Massive fire burns on mountain near western Canada city

Nearly 20,000 residents of a community in western Canada were on standby Wednesday as a wildfire engulfed a mountain overlooking the city of Port Alberni, the latest area threatened in the country's second-worst fire season on record.

Musk clashes with Altman after accusing App Store of favoring OpenAI

Elon Musk has accused Apple of unfairly favoring ChatGPT on its App Store and threatened legal action, triggering a fiery exchange with OpenAI CEO Sam Altman on Tuesday.

Passwords under threat as tech giants seek tougher security

Fingerprints, access keys and facial recognition are putting a new squeeze on passwords as the traditional computer security method -- but also running into public hesitancy.

New to The Street Signs VERB Technology Company to a 1-Year Media Campaign

Filming begins today; interviews with Executive Chairman Manuel Stotz sharing the Company's New TON Digital Asset Strategy conducted this morning

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB™ sample packs of four 50mg stick packs in each flavor distributed to convention attendeesWell-known fitness instructors, fitness celebrities, athletes, and influencers along with thousands of fitness enthusiasts and consumers sampled BUZZ BOMB™'s four bold flavorsAs part of its launch, Aspire plans on partnering with well-known athletes and influencers across fitness training and endurance sports to accelerate consumer awareness and uptakeBUZZ BOMB™ is available for purchase at buzzbomb.buzz, the Company's new E-commerce website

KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations

Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences CEO Reginald Swift, Ph.D. joins as Chief Scientific Officer with responsibility to shape KIFFIK's clinical strategy

US judge orders humane conditions for migrant detainees at NY site

A US judge ordered Tuesday that migrants being held at a Manhattan federal facility where individuals are often arrested after attending court hearings to fight deportation be kept in humane conditions.

Three killed in European wildfires as heatwave intensifies

Three men died and thousands were forced from their homes on Tuesday as wildfires fuelled by a heatwave scorched southern Europe.

US offers $5 mn reward for arrest of Haitian gang leader

The United States offered a $5 million reward on Tuesday for the arrest of Haitian gang leader Jimmy "Barbeque" Cherizier for allegedly violating US sanctions.

Soldier dies battling Montenegro wildfire

A Montenegrin soldier has died and another was seriously injured Tuesday when their water tanker overturned while fighting wildfires in the hills north of the capital.

Council of Europe cautions on weapon sales to Israel

The Council of Europe urged its member states on Tuesday to halt deliveries of weapons to Israel if they could be used for human rights violations.

Man killed in Spain wildfire as European heatwave intensifies

A man died after suffering burns and thousands fled their homes in Spain on Tuesday as wildfires fuelled by a heatwave scorched southern Europe.

Families mourn 40 years since deadly Japan Airlines crash

Family members of victims in the world's deadliest single-aircraft accident hiked Tuesday to the mountainous site in Japan where the plane went down, as the country marked 40 years since the tragedy that killed 520 people.

Japan boxing to adopt stricter safety rules after deaths of two fighters

Japanese boxing officials said on Tuesday they would introduce urine tests, stricter rules on weight loss to prevent dehydration and improve medical cover at bouts following the deaths of two fighters.

AI porn victims see Hong Kong unprepared for threat

For Hong Kong law student "C", AI-made pornography was a distant danger until a university classmate created graphic images of her and multiple other women.

Spanish police bust 'spiritual retreat' offering hallucinogenic drugs

Spanish police said Monday that they had dismantled a group accused of running a "spiritual retreat" that offered hallucinogenic drugs to clients from around the world.

MDaudit Finalizes Acquisition of Streamline Health

WELLESLEY, MA / ACCESS Newswire / August 12, 2025 / MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, has finalized its acquisition of Streamline Health Solutions, Inc., a leading provider of solutions that enable healthcare providers to improve financial performance The addition of Streamline's pre-bill integrity solutions to its robust billing compliance and revenue integrity platform positions MDaudit to bridge crucial RCM gaps, thereby mitigating billing compliance risks and strengthening and streamlining the revenue cycle.

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates

Click here to registerCompany plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register

MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin

Manuscript accepted for publication in Frontiers in Pharmacology, "Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism" details Ketamir-2's superior performance in two validated neuropathic pain models and supports advancement to Phase 2a clinical trials by year-end 2025.

Chinese man pleads guilty in US to smuggling protected turtles

A Chinese man faces up to five years in prison for trying to smuggle protected turtles worth more than $1 million from the United States to Hong Kong.

The Fort Worth Press - Boulevard (English)

Featured

Suspect in murder of Colombian footballer Escobar killed in Mexico

UK police probing Mandelson after Epstein revelations search properties

Last news